Proteomic resolution of the MASLD cardiometabolic spectrum identifies sex-driven endotypes and predicts systemic mortality | ||
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Endocrinología Experimental y Aplicada. Universidad Nacional de La Plata. Facultad de Ciencias Médicas. Centro de Endocrinología Experimental y Aplicada | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Centro de Investigacion Traslacional En Salud (cenitres) ; Facultad de Cs. de la Salud ; Universidad Maimonides | |
| dc.conicet.organizacion | Centro de Investigacion Traslacional En Salud (cenitres) ; Facultad de Cs. de la Salud ; Universidad Maimonides | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.contributor.author | Diambra, Luis Anibal | |
| dc.contributor.author | Sookoian, Silvia Cristina | |
| dc.contributor.author | Pirola, Carlos José | |
| dc.date.issued | 2026-07 | |
| dc.description.abstract | Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a heterogeneous condition where overlapping cardiometabolic risk factors challenge accurate prognostic prediction. Objectives: We aimed to define the molecular heterogeneity underlying MASLD clinical presentation, resolving disease patterns and identifying sub-phenotypes that account for prognostic differences in the general population. Design: We applied latent class analysis (LCA) to 48 806 UK Biobank participants with MRI-based proton density fat fraction (MRI-PDFF) data to define phenotypic subtypes over a >15-year follow-up. Large-scale proteomic profiling characterised the molecular basis of the identified prognostic patterns. This led to the derivation of a four-protein score (PS4), which was robustly validated for all-cause mortality prediction in an expanded cohort with/ without MRI-PDFF data (n=115 971). We used mediation analysis to assess the potential contribution of PS4 proteins to the observed class-outcome associations. Results: The LCA identified clinically distinct MASLD subtypes, revealing pronounced sexual dimorphism in disease severity and identifying high-risk prognostic subgroups. The derived PS4 score significantly outperformed established non-invasive scores in predicting all-cause mortality across the expanded cohort. The PS4 components, linked to hepatic lipid/one-carbon metabolism (FABP1, FTCD) and immune/vascular integrity (ADGRG1, GAST) pathways, were found to account for a significant fraction (10-20%) of the estimated effect of the patient's phenotypic class on mortality outcome. Conclusions: MASLD-driven proteomic shifts reflect biological pathways that connect hepatic metabolic dysfunction with long-term survival. By resolving the MASLD cardiometabolic spectrum, we identified high-risk endotypes that are not captured by traditional liver-centric scores. The PS4 represents a biologically grounded framework for deciphering the systemic consequences of MASLD. | es |
| dc.description.fil | Fil: Diambra, Luis Anibal. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Endocrinología Experimental y Aplicada. Universidad Nacional de La Plata. Facultad de Ciencias Médicas. Centro de Endocrinología Experimental y Aplicada; Argentina | |
| dc.description.fil | Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Centro de Investigacion Traslacional En Salud (cenitres) ; Facultad de Cs. de la Salud ; Universidad Maimonides; | |
| dc.description.fil | Fil: Pirola, Carlos José. Centro de Investigacion Traslacional En Salud (cenitres) ; Facultad de Cs. de la Salud ; Universidad Maimonides; . Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Diambra, Luis Anibal; Sookoian, Silvia Cristina; Pirola, Carlos José; Proteomic resolution of the MASLD cardiometabolic spectrum identifies sex-driven endotypes and predicts systemic mortality; B M J Publishing Group; Gut; 7-2026; 1-11 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0017-5749 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/294693 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.pagination | 1-11 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Gut | es |
| dc.language.iso | eng | es |
| dc.publisher | B M J Publishing Group | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2026-338674 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1136/gutjnl-2026-338674 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | MASH | es |
| dc.subject | PROTEOMICS | es |
| dc.subject | CARDIOVASCULAR RISK | es |
| dc.subject.classification | Gastroenterología y Hepatología | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Proteomic resolution of the MASLD cardiometabolic spectrum identifies sex-driven endotypes and predicts systemic mortality | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.cd4abe63-7595-4b00-aa38-6b97ec2544d0_B.pdf
- Tamaño:
- 5.18 MB
- Formato:
- Adobe Portable Document Format